Tempest Therapeutics (TPST) Market Capitalization (2012 - 2026)

Tempest Therapeutics has disclosed Market Capitalization across 15 years of filings, most recently posting $5.5 million for Q2 2026.

• In Q2 2026, Market Capitalization fell 81.88% year-over-year to $5.5 million; the TTM figure through Jun 2026 stood at $5.5 million (down 81.88% YoY), while the FY2025 annual figure was $14.1 million, down 39.27% from the prior year.
• Market Capitalization came in at $5.5 million for Q2 2026 at Tempest Therapeutics, down from $14.1 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $86.9 million in Q1 2024 to a low of $4.4 million in Q3 2023.
• Average Market Capitalization over 5 years is $31.3 million, with a median of $24.2 million recorded in 2022.
• Year-over-year, Market Capitalization surged 752.42% in 2024 and plunged 81.88% in 2026.
• Over 5 years, Market Capitalization stood at $12.1 million in 2022, then jumped by 460.76% to $67.8 million in 2023, then slumped by 65.67% to $23.3 million in 2024, then sank by 39.27% to $14.1 million in 2025, then sank by 61.32% to $5.5 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $5.5 million in Q2 2026, $14.1 million in Q4 2025, and $45.6 million in Q3 2025.